Asia Pacific Auto-injectors Market Size & Outlook, 2026-2033
Related Markets
Asia Pacific auto-injectors market highlights
- The Asia Pacific auto-injectors market generated a revenue of USD 2,134.6 million in 2025.
- The market is expected to grow at a CAGR of 14.3% from 2026 to 2033.
- In terms of segment, rheumatoid arthritis was the largest revenue generating disease indication in 2025.
- Diabetes is the most lucrative disease indication segment registering the fastest growth during the forecast period.
- Country-wise, Thailand is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 2,134.6 million |
| Market revenue in 2033 | USD 6,166.5 million |
| Growth rate | 14.3% (CAGR from 2026 to 2033) |
| Largest segment | Rheumatoid arthritis |
| Fastest growing segment | Diabetes |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anaphylaxis, Diabetes, Rheumatoid Arthritis, Other Therapies, Multiple Sclerosis |
| Key market players worldwide | Eli Lilly and Co, SHL Medical, AbbVie Inc, Amgen Inc, Owen Mumford, Ypsomed Holding AG, Teva Pharmaceutical Industries Ltd, Biogen Inc, Mylan, Pfizer Inc, Sanofi SA, Gerresheimer AG ADR |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.9% of the global auto-injectors market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,166.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Auto-Injectors Market Scope
Auto-Injectors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Mylan | View profile | 10001+ | https://www.mylan.in/ | |
| SHL Medical | View profile | 1001-5000 | Zug, Zug, Switzerland, Europe | https://www.shl-medical.com/ |
| Owen Mumford | View profile | 501-1000 | Oxford, Oxfordshire, United Kingdom, Europe | http://www.owenmumford.com/en/ |
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Gerresheimer AG ADR | View profile | 11660 | Klaus-Bungert-Strasse 4, Duesseldorf, NW, Germany, 40468 | https://www.gerresheimer.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Asia Pacific auto-injectors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to auto-injectors market will help companies and investors design strategic landscapes.
Rheumatoid arthritis was the largest segment with a revenue share of 31.1% in 2025. Horizon Databook has segmented the Asia Pacific auto-injectors market based on anaphylaxis, diabetes, rheumatoid arthritis, other therapies, multiple sclerosis covering the revenue growth of each sub-segment from 2021 to 2033.
The Asia Pacific auto-injectors market is experiencing significant growth, driven by the rising prevalence of chronic diseases, increased awareness about advanced drug delivery systems, and growing demand for self-administration options, contributing to market expansion.
Improvements in healthcare infrastructure and economic growth in countries such as China, India, and Japan further support this trend.
Additionally, government initiatives to enhance healthcare access and affordability boost market development. The entry of key market players and increasing investments in research and development for innovative auto-injector technologies are also pivotal in driving this region's growth.
Reasons to subscribe to Asia Pacific auto-injectors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific auto-injectors market databook
-
Our clientele includes a mix of auto-injectors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific auto-injectors market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific auto-injectors market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific auto-injectors market size, by country, 2021-2033 (US$M)
Asia Pacific Auto-Injectors Market Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
